Dr. Ma shares insights into his innovative "Leukemia-on-a-Chip" technology, its impact on CAR T-cell therapy, and the future of personalized medicine in treating leukemia.
3D Printing in Healthcare: From Surgical Tools to Organ Transplant Breakthroughs
How Spatial Genomics Is Revolutionizing Our Understanding of Health and Disease
CRISPR-Cas9: Shaping the Future of Targeted Drug Development
Revolutionizing Proteomics: Unlocking the potential of automation to overcome industry bottlenecks
The Power of Process Analytical Technology (PAT) in Pharmaceutical Manufacturing
Pharmaceutical Manufacturing Evolution: Mastering Process Development and Scale-Up for Market Success
Odors stimulate specific brain cells involved in rapid decision making
Researchers identify a new approach to controlling bacterial infections
Researchers introduce new approach for accurately assessing cell composition in the pancreas
Researchers develop new approach to improve the accuracy of RNA sequencing
Academia's drug discovery challenges: Exploring the "publication landfill"
Standard bacterial test for raw, organic milk needs to be updated
Using three-dimensional printing (3DP) to produce complex tissue engineering scaffolds
How tissue engineering and regenerative medicine use bioprinting
Tumor targeting using nanoparticle-based drug and gene delivery
Delivering oligonucleotides the smart way
How is three dimensional bioprinting used for tissue and disease modeling
Forensic Cannabis Analysis: Differentiating Hemp from Marijuana
Dr Tanya Nguyen
In this new episode of omg OMx, Kate Stumpo speaks to Sapient's Tanya Nguyen about the role of
omics and mass spectrometry in neurosciences.
Dr. Chao Ma
NewsMedical speaks with Chao Ma, Ph.D. a Research Assistant Professor at New York University Tandon School of Engineering, ahead of his presentation at SLAS 2024.
In this interview, we speak with Jack O'Meara, co-founder and CEO of Ochre Bio, a pioneering force in liver disease treatment. O'Meara shares insights into Ochre Bio's innovative RNA therapies, their approach to tackling liver disease, and the company's vision for the future.